Oxford University scientists have developed a diagnostic test capable of detecting the SARS-CoV-2 virus in five minutes. The test can differentiate between and negative samples or other respiratory pathogens such as influenza. It works directly on the throat swabs from Covid-19 patients, and quickly labels the virus particles on the sample with the help of fluorescent DNA strips.
Genalyte, a healthcare analytics and diagnostics company, has obtained Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its SARS-CoV-2 multi-antigen serology panel. The test identifies IgG and IgM antibodies produced by the body to fight the SARS-CoV-2 virus. The panel, along with the FDA-approved Maverick™ Diagnostic System, is expected to improve antibody testing and deliver accurate results in 20 minutes.
Go deeper with GlobalData
bioLytical Laboratories, an HIV diagnostic products company, has launched a one-minute antibody test for Covid-19 in Europe after receiving CE mark approval. The test uses flow-through technology to deliver fast results. bioLytical aims to start manufacturing of the new test kits and rapidly distribute them across the globe.
See Also:
Chembio Diagnostics, a diagnostic company, has submitted an Emergency Use Authorisation (EUA) application for the DPP SARS-CoV-2 antigen test system to the FDA. The test system can detect SARS-CoV-2 antigens in 20 minutes and includes an antigen test cartridge, a nasal swab, and a micro reader optical analyser.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
